When a manufacturing plant in India halted production in 2022, cancer patients in America were told their chemotherapy drugs were experiencing a shortage and doctors had to decide who would get the remaining supply. Our experts explain the effects of this ongoing shortage and how we can make sure it doesn’t happen again.
Guest Information:
- Barbara Barnett, Cancer Patient
- Dr. Julie Gralow, Chief Medical Officer & Executive Vice President, American Society of Clinical Oncology
- Mark Fleury, Policy Principal, American Cancer Society Cancer Action Network
Leave a Reply